FDA Approved: AMONDYS 45 — Original Application (Sarepta Therapeutics, Inc.)

View source ↗

Summary

FDA approves AMONDYS 45 (casimersen) via an original application for Duchenne muscular dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• AMONDYS 45 (Casimersen)

Snippet

ORIG AP for AMONDYS 45 (CASIMERSEN)